BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30
• 31

• WuXi PharmaTech Co., Ltd. Presents 2014 Life Science And Chemistry Awards

  December 8, 2014

   · 

  3 min read
• Drug Development

  Ariad Pharmaceuticals, Inc. Announces Long-Term Safety And Efficacy Data Of Ponatinib From Phase 2 Pace Clinical Trial

  December 8, 2014

   · 

  15 min read
• Definiens AG Releases Tissue Studio® 4.0 For Quantitative Digital Pathology

  December 8, 2014

   · 

  1 min read
• BioMidwest

  Medtronic, Inc. CFO Gary Ellis To Speak At Oppenheimer Healthcare Conference

  December 8, 2014

   · 

  1 min read
• Actavis To Present Levomilnacipran And Vilazodone Data At American College Of Neuropsychopharmacology 53rd Annual Meeting

  December 8, 2014

   · 

  2 min read
• BioMidwest

  Medtronic, Inc. Release: The Bakken Invitation Announces 2014 Honorees: 10 Inspiring People Who Live On And Give On

  December 8, 2014

   · 

  6 min read
• BioMidwest

  Critical Path Institute Receives Third Grant To Accelerate Tuberculosis Diagnostics

  December 8, 2014

   · 

  3 min read
• Business

  Good Start Genetics, Inc. Announces Exclusive License Agreement With Johns Hopkins University For Key Assets In Preimplantion Genetic Screening

  December 8, 2014

   · 

  3 min read
• Drug Development

  Celgene Release: Age, Renal Impairment and Depth of Response Analyses of the First™ (MM-020/IFM 07-01) Study of Continuous REVLIMID® (Lenalidomide) Plus Low-Dose Dexamethasone In Newly-Diagnosed Multiple Myeloma Presented at American Society of Hematology

  December 8, 2014

   · 

  21 min read
• Otsuka Pharmaceutical Co., Ltd. Release: U.S. FDA Approves The Labeling Update Of Abilify Maintena® (Aripiprazole) For Extended-Release Injectable Suspension To Describe New Clinical Data For The Treatment Of Acutely Relapsed Adults With Schizophrenia

  December 8, 2014

   · 

  17 min read